Surgical outcomes in each vascular resection range and reconstruction method in patients with portal vein and superior mesenteric vein resection for pancreatic head cancer Japan-Korea Cooperative Project
Not Applicable
Recruiting
- Conditions
- Pancreatic cancer
- Registration Number
- JPRN-UMIN000040398
- Lead Sponsor
- Department of Gastrointestinal and Pediatric Surgery,Tokyo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 252
Inclusion Criteria
Not provided
Exclusion Criteria
Unresectable PDAC with distant metastasis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival
- Secondary Outcome Measures
Name Time Method Morbidity and mortality Disease-free survival R0 resection rate histological invasion rate of the resected PV/SMV Morbidity and mortality Initial recurrence patterns
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie vascular resection outcomes in pancreatic head cancer patients?
How does portal vein resection compare to standard-of-care in pancreatic cancer surgical outcomes?
Which biomarkers correlate with successful vascular reconstruction in pancreatic head cancer?
What are the adverse events associated with superior mesenteric vein resection in this trial?
Are there combination therapies improving survival post-vascular resection for pancreatic cancer?